4-amino-3-phenylbutyric acid has been researched along with Cognition Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anisimova, TI; Bondarchuk, IuL; Chutko, LS; Iakovenko, EA; Nikishena, IS; Surushkina, SIu | 1 |
| Bagmetova, VV; Berestovitskaia, VM; Borodkina, LE; Tiurenkov, IN; Vasil'eva, OS | 1 |
2 other study(ies) available for 4-amino-3-phenylbutyric acid and Cognition Disorders
| Article | Year |
|---|---|
[Cognitive and emotional impairments in patients with protracted anxiety-phobic disorders].
Topics: Acute Disease; Adolescent; Adult; Chronic Disease; Cognition Disorders; gamma-Aminobutyric Acid; Humans; Middle Aged; Phobic Disorders; Tranquilizing Agents; Treatment Outcome; Young Adult | 2014 |
[Fenibut and its citrate prevent psychoneurological disorders caused by chronic stress (paradoxical sleep deprivation)].
Topics: Adrenal Glands; Animals; Avoidance Learning; Behavior, Animal; Citrates; Cognition Disorders; gamma-Aminobutyric Acid; Humans; Male; Maze Learning; Neurotic Disorders; Rats; Sleep Deprivation; Sleep, REM; Stomach; Stress, Physiological; Thymus Gland; Tranquilizing Agents | 2012 |